HREP: A Protein Implicated in Heart Disease and Cancer (G374286)

Target Name: FBXW10B

NCBI ID: G374286

FBXW10B

HREP: A Protein Implicated in Heart Disease and Cancer

FacebookeXpressW10B, also known as HREP, is a protein that is expressed in the human heart and has been shown to play a role in the development and progression of heart disease. The HREP gene has also been linked to the development of certain types of cancer.

HREP is a member of the superfamily of cytoplasmic proteins, which are characterized by the presence of a cytoplasmic tail that is composed of a complex of amino acids. These tails are often involved in the regulation of cellular processes such as cell adhesion, migration, and signaling.

One of the unique features of HREP is its ability to interact with other proteins that are expressed in the heart, including the transcription factor NF-kappa-B. This interaction between HREP and NF-kappa-B has been shown to play a role in the regulation of heart function and the development of certain types of cancer.

In addition to its role in the heart, HREP has also been shown to be involved in the development and progression of certain types of cancer. For example, studies have shown that high levels of HREP are associated with an increased risk of certain types of cancer, such as breast, ovarian, and prostate cancer.

The discovery of HREP as a potential drug target or biomarker has significant implications for the treatment of heart disease and certain types of cancer. Researchers are currently working to develop new treatments for these conditions that target HREP and its associated pathways.

One approach that is being explored is the use of small molecules to inhibit the activity of HREP. These molecules, called HREP inhibitors, can be used to treat a variety of conditions that are characterized by the over-expression of HREP, such as heart disease and certain types of cancer.

Another approach that is being explored is the use of antibodies to target HREP. These antibodies can be used to treat a variety of conditions that are characterized by the over-expression of HREP, such as heart disease and certain types of cancer.

In addition to its potential as a drug target or biomarker, HREP is also being studied for its potential role in the development and progression of certain types of cancer. Researchers are working to develop new treatments for these conditions that target HREP and its associated pathways.

Overall, HREP is a protein that has significant implications for the treatment of heart disease and certain types of cancer. Its ability to interact with other proteins in the heart and its association with the development of certain types of cancer make it an attractive target for research and development of new treatments. As research continues to progress, it is likely that new treatments for heart disease and certain types of cancer will be developed that target HREP and its associated pathways.

Protein Name: F-box And WD Repeat Domain Containing 10B

The "FBXW10B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FBXW10B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets